Abstract
Benzodiazepines are first-line therapy for treatment of alcohol withdrawal syndrome (AWS). Longer acting benzodiazepines may provide a smoother withdrawal, while shorter-acting benzodiazepines may be preferred in patients who are elderly or have significant hepatic impairment. Front loading, fixed dose and symptom-triggered benzodiazepine dosing strategies may be used when treating moderate to severe AWS in the hospital setting. Other drugs may be appropriate as adjuncts to benzodiazepine therapy or in the treatment of mild to moderate AWS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 2014;28(5):401–10.
Carlson RW, Kumar NN, Wong-Mckinstry E, et al. Alcohol withdrawal syndrome. Crit Care Clin. 2012;28(4):549–85.
McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79(8):854–62.
Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353–7.
Amato L, Minozzi S, Vecchi S, et al. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010;3:CD005063.
Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ. 1999;160(5):649–55.
Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994;272(7):519–23.
Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium: an evidence-based practice guideline. Arch Intern Med. 2004;164(13):1405–12.
Hoffman RS, Weinhouse GL. Management of moderate and severe alcohol withdrawal syndromes. Topic 323 Version 23.0. 2013. http://www.uptodate.com/contents/management-of-moderate-and-severe-alcohol-withdrawal-syndromes. Accessed 2014.
Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278(2):144–51.
Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig. 2014;34(1):63–80.
Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348(18):1786–95.
Minozzi S, Amato L, Vecchi S, et al. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010;3:CD005064.
Kirkwood CK, Melton ST. Anxiety disorders I: generalized anxiety, panic, and social anxiety disorders. In: Diro JT, Talert RL, Yee CG, et al., editors. Pharmacotherapy: a pathophysiological approach. 7th ed. New York: McGraw-Hill; 2008. p. 1161–78.
Disclosure
This article was adapted from CNS Drugs 2014;28(5):401–10 [1] by salaried/contracted employees of Adis/Springer. The preparation of these articles was not supported by any external funding.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Benzodiazepines are the mainstay of treatment for acute alcohol withdrawal syndrome. Drugs Ther Perspect 30, 395–398 (2014). https://doi.org/10.1007/s40267-014-0152-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-014-0152-2